Managing COVID-19 Testing Demands in your Health System: Key Considerations for CFOs Before Investing in New Technology


The drum beat for managing the COVID-19 pandemic from public health leaders continues to be test, test, test. Before investing in new technology, there are several considerations that chief financial officers should consider.


Getting the Best Pricing for Reference Laboratory Services


The COVID pandemic has produced many new challenges for hospital-based laboratories. One area that laboratory leaders may find immediate cost reduction opportunities is through a review of utilization and pricing for reference laboratory services. 


Our National Lab Experiment: Testing for the SARS-CoV-2 Coronavirus


As a nurse with decades of experience, I have been perplexed by the ongoing reporting challenges related to testing for COVID-19. There are a multitude of vendors providing the various tests that determine if a patient is infected with the active virus and those that detect antibodies that indicate prior infection. There is a broad variation in turnaround time for results — from a few hours to a few days to even weeks for some. It is an unprecedented health care issue with an unprecedented response.


COVID-19 Response Requires Innovation from Hospital Labs: 4 Actions to Take Now


At the beginning of the COVID-19 pandemic, medical laboratories immediately experienced a decline in testing volume. And, while the test volumes are inching upward as labs find their footing in the new pandemic environment, the rate of recovery is slower than anticipated.


Chronic Pain Doesn’t Go Away During a Pandemic. Here’s How to Develop a Program to Connect These Patients Back to the Care They Need


With over 50 million U.S. adults experiencing chronic pain daily, the need for patient care hasn’t disappeared, but it may have grown more complicated due to the pandemic.   


Drug Importation, eh?

[Full disclosure: your author is a Canadian import] After several months of D.C. chatter and countless state importation bills, FDA recently took two significant regulatory steps to allow for prescription drug importation from Canada. Wait, you thought importation was already happening in Florida? Not quite. More